Rapt Therapeutics Inc (NASDAQ:RAPT)

22.73
Delayed Data
As of Sep 23
 -0.39 / -1.69%
Today’s Change
9.86
Today|||52-Week Range
40.74
-38.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2017

2018

--

--
Revenue and IncomeNet Revenues0.000.00------
Depreciation And Amortization1.4M1.2M----
 
 
 
 
Operating ExpensesGross Income-1.4M-1.2M----
 
 
 
General Expenses27.9M35.7M----
 
 
 
Research And Development25.6M31.8M----
 
 
 
Total Operating Expenses29.3M36.9M----
 
 
 
 
Non-Operating ExpensesOperating Income-29.3M-36.9M----
 
 
 
Other Expenses216.0K800.0K----
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-29.1M-36.1M----
 
 
 
Net Income-29.1M-36.1M----
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.5M23.5M----
 
 
 
Shares To Calculate EPS Diluted23.5M23.5M----
 
 
 
 
Earnings Per ShareEPS-$1.24-$1.54----
 
 
 
EPS Diluted-$1.24-$1.54----